Iradimed (IRMD) Net Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -315.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,018.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 399.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | 446.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 446.00 |
| Dec 31, 2025 | 367.00 |
| Sep 30, 2025 | 74.00 |
| Jun 30, 2025 | 281.00 |
| Mar 31, 2025 | 382.00 |
| Dec 31, 2024 | -624.00 |
| Sep 30, 2024 | 393.00 |
| Jun 30, 2024 | 1,236.00 |
| Mar 31, 2024 | 847.00 |
| Dec 31, 2023 | 1,041.00 |
| Sep 30, 2023 | 1,674.00 |
| Jun 30, 2023 | 5,700.00 |
| Mar 31, 2023 | 162.00 |
| Dec 31, 2022 | -505.00 |
| Sep 30, 2022 | 92.00 |
| Jun 30, 2022 | 284.00 |
| Mar 31, 2022 | -167.00 |
| Dec 31, 2021 | 1,232.00 |
| Sep 30, 2021 | -790.00 |
| Jun 30, 2021 | -339.00 |
| Mar 31, 2021 | 320.00 |
| Dec 31, 2020 | 472.00 |
| Sep 30, 2020 | 1,058.00 |
| Jun 30, 2020 | -3,755.00 |
| Mar 31, 2020 | 2,491.00 |
| Dec 31, 2019 | 2,025.00 |
| Sep 30, 2019 | 430.00 |
| Jun 30, 2019 | 3.00 |
| Mar 31, 2019 | -358.00 |
| Dec 31, 2018 | -686.00 |
| Sep 30, 2018 | 873.00 |
| Jun 30, 2018 | -490.00 |
| Mar 31, 2018 | -944.00 |
| Dec 31, 2017 | -15.00 |
| Sep 30, 2017 | -285.00 |
| Jun 30, 2017 | -1,521.00 |
| Mar 31, 2017 | -1,923.00 |
| Dec 31, 2016 | -420.00 |
| Sep 30, 2016 | 982.00 |
| Jun 30, 2016 | 249.00 |